For the quarter ending 2025-09-30, FHTX has $204,962K in assets. $294,620K in debts. $89,334K in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 89,334 | 72,572 | ||
| Marketable securities | 90,944 | 126,093 | ||
| Restricted cash | 1,250 | 1,250 | ||
| Prepaid expenses and other current assets | 2,589 | 3,927 | ||
| Total current assets | 184,117 | 203,842 | ||
| Property and equipment, net | 8,662 | 9,514 | ||
| Restricted cash | 2,000 | 2,000 | ||
| Other assets | 5 | 6 | ||
| Operating lease right-of-use assets | 10,178 | 10,874 | ||
| Total assets | 204,962 | 226,236 | ||
| Accounts payable | 3,212 | 3,322 | ||
| Accrued expenses and other current liabilities | 9,822 | 8,564 | ||
| Operating lease liabilities | 6,755 | 6,176 | ||
| Deferred revenue | 65,299 | 59,724 | ||
| Total current liabilities | 85,088 | 77,786 | ||
| Operating lease liabilities, net of current portion | 15,774 | 17,522 | ||
| Deferred revenue, net of current portion | 193,102 | 206,830 | ||
| Other liabilities | 656 | 757 | ||
| Total liabilities | 294,620 | 302,895 | ||
| Common stock, 0.0001 par value 175,000,000 shares authorized at september30, 2025 and december31, 2024 56,542,877 shares issued and outstanding at september30, 2025 and 55,594,131 shares issued and outstanding at december31, 2024 | 6 | 6 | ||
| Additional paid-in capital | 521,115 | 518,333 | ||
| Accumulated other comprehensive gain | 24 | -44 | ||
| Accumulated deficit | -610,803 | -594,954 | ||
| Total stockholders deficit | -89,658 | -76,659 | ||
| Total liabilities and stockholders deficit | 204,962 | 226,236 | ||
Foghorn Therapeutics Inc. (FHTX)
Foghorn Therapeutics Inc. (FHTX)